Dkk-3, a Secreted Wnt Antagonist, Suppresses Tumorigenic Potential and Pulmonary Metastasis in Osteosarcoma
Osteosarcoma (OS) is the most common primary bone malignancy with a high propensity for local invasion and distant metastasis. Despite current multidisciplinary treatments, there has not been a drastic change in overall prognosis within the past 2 decades. Dickkopf-3 protein (Dkk-3/REIC) has been kn...
Main Authors: | Carol H. Lin, Yi Guo, Samia Ghaffar, Peter McQueen, Jonathan Pourmorady, Alexander Christ, Kevin Rooney, Tao Ji, Ramez Eskander, Xiaolin Zi, Bang H. Hoang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Sarcoma |
Online Access: | http://dx.doi.org/10.1155/2013/147541 |
Similar Items
-
Transcriptional silencing of the Wnt-antagonist DKK1 by promoter methylation is associated with enhanced Wnt signaling in advanced multiple myeloma.
by: Kinga A Kocemba, et al.
Published: (2012-01-01) -
Downregulation of the Wnt antagonist Dkk2 links the loss of Sept4 and myofibroblastic transformation of hepatic stellate cells
by: Yanagida, Atsuko
Published: (2011) -
Rational design of DKK3 structure-based small peptides as antagonists of Wnt signaling pathway and in silico evaluation of their efficiency.
by: Mansour Poorebrahim, et al.
Published: (2017-01-01) -
Roles of Wnt3a and Dkk1 in experimental periodontitis
by: Jianqi Liu, et al.
Published: (2017-09-01) -
Modification and Transport of DKK2 (Dickkopf-2) Protein in Wnt Signaling
by: Jhe-Ming Chen, et al.
Published: (2007)